Live Breaking News & Updates on Novo Holdings Equity Asia

Stay updated with breaking news from Novo holdings equity asia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novo Nordisk's obesity drug Wegovy cuts risk of death by 18 per cent, trial data shows

Novo Nordisk’s weight-loss drug Wegovy cut the risk of death by 18 per cent in a trial that the Danish pharmaceutical company hopes will convince more health. ....

United States , Martin Holst Lange , Hannah Kuchler , Eli Lilly , American Heart Association , Novo Nordisk , Drug Administration , Holst Lange , New England Journal ,

Small Business Tech Roundup: Using ChatGPT For Accounting? You May Want To Think Again.

Also this week: Google introduces new tools for the holiday season and new AI tech can make grant writing easier. ....

Brad Paterson , Amelia Wattenberger , David Wood , Merchant Center , Fast Company , Brigham Young University , Grant Assistant , Business Attribute , Google Maps , Business Profile , Product Studio ,

Demand for weight-loss drugs fuels global rise in counterfeits

The Pharmaceutical Security Institute said it is working with agencies, including Europol, Interpol and U.S. Homeland Security, as well as companies that help identify counterfeit products ....

United Kingdom , United States , World Health Organization , Al Qahirah , Lilly Mounjaro , Novo Nordisk Ozempic , Eli Lilly , Yoav Keren , Novo Ozempic , Jim Mancuso , Regulatory Agency , Ireland Health Products Regulatory Authority , Drug Administration , U Pharmaceutical Security Institute , Novo Nordisk , A World Health Organization , Log Increate Free , Pharmaceutical Security Institute , Homeland Security , Intellectual Property Rights Coordination , North America , Middle East , Health Products Regulatory Authority ,

Novo Nordisk acquires blood pressure drug for $1.3B

COPENHAGEN: Danish drugmaker Novo Nordisk, which specialises in anti-diabetic and anti-obesity treatments, announced on Monday it is acquiring hypertension drug ocedurenone for $1.3 billion ....

Novo Nordisk , Terms Of Service , Manila Times , P3 3b ,

Wegovy: Novo Nordisk India head eyes 2026 launch for obesity drug Wegovy, warns against copycats

Novo Nordisk plans to bring its weight-loss drug, Wegovy, to India in 2026. The company aims to secure regulatory approvals and ensure sufficient supply before entering the Indian market, where obesity rates are high. Counterfeit versions of Wegovy are already being sold online, but Novo Nordisk urges patients not to buy them due to safety concerns. ....

United Kingdom , Eli Lilly Mounjaro , Vikrant Shrotriya , National Family Health , Healthcare Management Analytics Programme , Novo Nordisk , Offering College , Indian School Of Business , Healthcare Expertise , India Managing Director Vikrant , Eli Lilly , National Family Health Survey , Obesity Rates , Blockbuster Weight Loss ,